💊

Thiotepa Riemser

thiotepa

Transplante de Células-Tronco Hematopoéticas;Neoplasias

✅ Autorizado Genérico

✅

Nenhum alerta ativo

Este medicamento não apresenta escassez contínua, cartas de segurança ou recolhimentos.

Para que serve

Thiotepa Riemser is indicated, in combination with other chemotherapy medicinal products: with or without total body irradiation (TBI), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases in adult and paediatric patients; when high dose chemotherapy with HPCT support is appropriate for the treatment of solid tumours in adult and paediatric patients. Thiotepa Riemser is indicated, in combination with other chemotherapy medicinal products: with or without total body irradiation (TBI), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases in adult and paediatric patients; when high dose chemotherapy with HPCT support is appropriate for the treatment of solid tumours in adult and paediatric patients

⚠️ Segurança do paciente

Página oficial da EMA

https://www.ema.europa.eu/en/medicines/human/EPAR/thiotepa-riemser